Key Highlights

  • NAHL Group plc (LSE:NAH) shares gained 5.56% on Wednesday 30 September 2026, the day it published interim results for the six months to 30 June 2026.
  • The July trading update flagged first-half Revenue of about £19.7 million, up 3%, and underlying operating profit of about £3.4 million, up 8%.
  • Free Cash Flow jumped 42% to £2.1 million and net Debt fell 68% to £1.0 million.
  • On 28 September NAHL secured a £1.85 million settlement from a supplier dispute, income that was not included in forecasts.
  • The board is exploring Options to accelerate value for shareholders, and management will present results to investors on 6 October.

NAHL Group (LSE:NAH) Climbs on Results Day

Shares in NAHL Group plc (LSE:NAH), the Kettering-based Marketing and services group focused on the UK consumer legal market, rose 5.56% on Wednesday. The company released its unaudited interim results for the first half of 2026 before the market opened, and a notification of a change in a major shareholding was also published during the day, adding to trading interest in the small-cap stock.

Why NAHL Shares Are in Focus

NAHL operates through two divisions. Consumer Legal Services includes National Accident Helpline, one of the best-known personal injury brands in the UK, and National Accident Law, its in-house law firm. Critical Care, through Bush & Co, provides expert witness reports, case management and care services for people who have suffered catastrophic and serious injuries.

The group has been through a difficult period, including heavy losses in 2024, but has since returned to profitability. In 2025 it posted a pre-tax profit of £4.4 million, and in the first half of 2026 it has continued to grow Earnings while rapidly paying down debt. The board has also said it is actively exploring suitable options to accelerate value for shareholders, which many investors interpret as potential corporate activity.

Key Reasons Behind the 5.56% Gain Today

The first driver is the results. Interim figures landed on top of a July trading update that flagged group revenue of about £19.7 million, up 3%, and underlying operating profit of around £3.4 million, up 8%. Consumer Legal Services grew revenue 2% to £11.3 million while profit before tax rose 52% to £1.2 million, helped by an 11% rise in enquiries into National Accident Helpline. Critical Care revenue rose around 3% to £8.5 million, with profit before tax marginally higher at £2.7 million.

The second driver is cash. Free cash flow increased 42% to £2.1 million, cutting net debt by 68% to £1.0 million from £3.2 million at the end of 2025. A nearly debt-free Balance Sheet gives the board more flexibility, whether for returning cash, investing in growth or pursuing strategic options.

The third driver is the unexpected settlement. On 28 September NAHL announced it had reached a £1.85 million full and final settlement in a contract dispute with a supplier, payable by 15 October 2026. The board had not accrued this income or included it in forecasts, so it represents a one-off boost to cash and earnings. The group will forgo future revenue under the contract, but that revenue was not expected to be significant.

The fourth Factor is the strategic review. Investors remain alert to any update on options to unlock value, particularly after the board previously explored a sale of the Critical Care business.

Market and Regulatory Backdrop

The personal injury market has changed significantly after UK reforms to whiplash claims, forcing firms like NAHL to adapt their models. The company has also had to manage rising online marketing costs after changes to search engine algorithms and the introduction of AI-generated search summaries in 2024. Management responded by keeping enquiry Acquisition costs in line with historical norms.

What Investors Are Watching Next

Management will present the interim results to investors on 6 October 2026. Key issues include the outcome of the strategic review, receipt of the £1.85 million settlement, enquiry trends at National Accident Helpline, case management performance in Critical Care, and any return to dividends. Risks include regulatory change, marketing cost Inflation and the timing of claim settlements, which can make cash flow lumpy.